Ann: PTX-200 AML expansion after another complete response, page-25

I'll try and have a look for you mate.

But I can say that it's not just dragging without direction.

The PTX-200 program was able to show 3 complete responses in the original cohort...The next structured phase was the increase dosage from 35 to 45mg...It did get held up by the Delta strain late last year, the trial is being conducted from the Moffitt Cancer Center in Florida which is a red state with rather low vaccination rates unfortunately at the time of recruitment.

I believe everything is well on track now for a completion possibly late current quarter or early next quarter...It seems this latest complete response in AML has caused the trial lead to adjust the recruitment for a few more AML patients understandably...This could give PTX much greater clarity and direction for their phase 2 trial and targeted Cancer.

Sorry to hear about your Scottish friend @Wasabibarako ...It can be a cruel world at times...We can only hope that these cancers become a problem of the past for our children or grandchildren...Take care mate.